A
Alivexis develops custom biopharmaceutical solutions through advanced genetic engineering and personalized medicine techniques, addressing the need for tailored therapies in the pharmaceutical industry. The company focuses on optimizing drug efficacy and safety by creating treatments that are specifically designed to meet individual patient profiles.
Updated 4 months ago
Funding
$61.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Alivexis develops custom biopharmaceutical solutions through advanced genetic engineering and personalized medicine techniques, addressing the need for tailored therapies in the pharmaceutical industry. The company focuses on optimizing drug efficacy and safety by creating treatments that are specifically designed to meet individual patient profiles.